Lyell Immunopharma Inc
NASDAQ:LYEL
Lyell Immunopharma Inc
NASDAQ:LYEL
Price:
19.12
USD
-7.94%
Market Closed
Market Cap:
$445.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
US |
|
C
|
Copernicus Securities SA
WSE:CRS
|
PL |
|
Gansu Yasheng Industrial Group Co Ltd
SSE:600108
|
CN |
|
H
|
Hlt Global Bhd
KLSE:HLT
|
MY |
|
Acrux Ltd
ASX:ACR
|
AU |
|
Champion Building Materials Co Ltd
TWSE:1806
|
TW |
|
A
|
AngloGold Ashanti Ltd
XBER:AOD1
|
ZA |
|
S2 Resources Ltd
ASX:S2R
|
AU |
|
N
|
Nippon Television Holdings Inc
TSE:9404
|
JP |
Income Statement
Earnings Waterfall
Lyell Immunopharma Inc
Lyell Immunopharma Inc
Income Statement
Lyell Immunopharma Inc
Lyell Immunopharma Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Revenue |
8
N/A
|
9
+15%
|
8
-5%
|
10
+20%
|
11
+5%
|
9
-18%
|
42
+378%
|
39
-7%
|
85
+117%
|
84
-1%
|
48
-42%
|
49
+0%
|
0
-100%
|
0
-42%
|
0
-22%
|
0
+7%
|
0
-3%
|
0
+7%
|
0
-8%
|
0
-32%
|
0
-12%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(220)
|
(243)
|
(203)
|
(217)
|
(225)
|
(273)
|
(281)
|
(259)
|
(272)
|
(265)
|
(258)
|
(251)
|
(247)
|
(240)
|
(226)
|
(218)
|
(220)
|
(223)
|
(216)
|
(202)
|
(202)
|
|
| Selling, General & Administrative |
(47)
|
(55)
|
(64)
|
(72)
|
(89)
|
(107)
|
(118)
|
(123)
|
(117)
|
(102)
|
(91)
|
(80)
|
(67)
|
(61)
|
(54)
|
(51)
|
(52)
|
(53)
|
(51)
|
(50)
|
(45)
|
|
| Research & Development |
(182)
|
(198)
|
(148)
|
(155)
|
(135)
|
(137)
|
(131)
|
(138)
|
(164)
|
(171)
|
(178)
|
(183)
|
(186)
|
(183)
|
(178)
|
(175)
|
(173)
|
(175)
|
(168)
|
(156)
|
(159)
|
|
| Other Operating Expenses |
9
|
10
|
9
|
10
|
(1)
|
(30)
|
(32)
|
2
|
10
|
8
|
11
|
12
|
6
|
4
|
6
|
8
|
4
|
6
|
3
|
3
|
2
|
|
| Operating Income |
(212)
N/A
|
(234)
-11%
|
(194)
+17%
|
(207)
-6%
|
(214)
-4%
|
(264)
-23%
|
(239)
+10%
|
(220)
+8%
|
(187)
+15%
|
(181)
+3%
|
(210)
-16%
|
(202)
+4%
|
(247)
-22%
|
(240)
+3%
|
(226)
+6%
|
(218)
+4%
|
(220)
-1%
|
(223)
-1%
|
(216)
+3%
|
(202)
+6%
|
(202)
+0%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
6
|
4
|
2
|
1
|
1
|
1
|
2
|
3
|
6
|
10
|
14
|
20
|
23
|
26
|
27
|
26
|
24
|
21
|
18
|
15
|
13
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(37)
|
0
|
0
|
(41)
|
(5)
|
(15)
|
(18)
|
(13)
|
(13)
|
(16)
|
(13)
|
(13)
|
(151)
|
(138)
|
(139)
|
(139)
|
(68)
|
|
| Total Other Income |
2
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
3
|
4
|
4
|
5
|
2
|
2
|
2
|
(0)
|
5
|
5
|
6
|
1
|
(18)
|
|
| Pre-Tax Income |
(204)
N/A
|
(230)
-13%
|
(192)
+17%
|
(205)
-7%
|
(250)
-22%
|
(263)
-5%
|
(237)
+10%
|
(258)
-9%
|
(183)
+29%
|
(182)
+1%
|
(210)
-15%
|
(190)
+9%
|
(235)
-23%
|
(228)
+3%
|
(210)
+8%
|
(204)
+3%
|
(343)
-68%
|
(335)
+2%
|
(332)
+1%
|
(326)
+2%
|
(274)
+16%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(204)
|
(230)
|
(192)
|
(205)
|
(250)
|
(263)
|
(237)
|
(258)
|
(183)
|
(182)
|
(210)
|
(190)
|
(235)
|
(228)
|
(210)
|
(204)
|
(343)
|
(335)
|
(332)
|
(326)
|
(274)
|
|
| Net Income (Common) |
(204)
N/A
|
(230)
-13%
|
(192)
+17%
|
(205)
-7%
|
(250)
-22%
|
(263)
-5%
|
(237)
+10%
|
(258)
-9%
|
(183)
+29%
|
(182)
+1%
|
(210)
-15%
|
(190)
+9%
|
(235)
-23%
|
(228)
+3%
|
(210)
+8%
|
(204)
+3%
|
(343)
-68%
|
(335)
+2%
|
(332)
+1%
|
(326)
+2%
|
(274)
+16%
|
|
| EPS (Diluted) |
-16.84
N/A
|
-18.96
-13%
|
-15.83
+17%
|
-17.13
-8%
|
-20.61
-20%
|
-21.56
-5%
|
-19.24
+11%
|
-20.81
-8%
|
-14.67
+30%
|
-14.57
+1%
|
-16.74
-15%
|
-15.12
+10%
|
-18.7
-24%
|
-17.96
+4%
|
-16.46
+8%
|
-15.94
+3%
|
-26.23
-65%
|
-22.7
+13%
|
-22.43
+1%
|
-17.83
+21%
|
-16.06
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
